Doximity (NASDAQ:DOCS) Coverage Initiated at Stephens

Stephens began coverage on shares of Doximity (NASDAQ:DOCS - Free Report) in a report published on Friday morning, Marketbeat Ratings reports. The brokerage issued an equal weight rating and a $55.00 price objective on the stock.

DOCS has been the topic of several other reports. JPMorgan Chase & Co. increased their price target on shares of Doximity from $30.00 to $48.00 and gave the company a "neutral" rating in a report on Thursday, November 21st. Barclays lifted their price target on Doximity from $52.00 to $75.00 and gave the stock an "overweight" rating in a report on Monday, November 11th. The Goldman Sachs Group started coverage on Doximity in a report on Friday, November 15th. They issued a "neutral" rating and a $58.00 price objective on the stock. Wells Fargo & Company raised Doximity from an "underweight" rating to an "equal weight" rating and lifted their target price for the stock from $19.00 to $41.00 in a report on Friday, November 8th. Finally, Evercore ISI upped their price target on shares of Doximity from $34.00 to $45.00 and gave the company an "in-line" rating in a research note on Tuesday, October 8th. Thirteen research analysts have rated the stock with a hold rating, six have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, Doximity has a consensus rating of "Hold" and an average price target of $52.59.

Doximity Stock Up 4.8 %

Shares of DOCS traded up $2.65 during trading hours on Friday, hitting $57.83. The company had a trading volume of 7,961,393 shares, compared to its average volume of 1,781,185. The business has a fifty day moving average of $48.82 and a 200-day moving average of $38.57. The firm has a market cap of $10.80 billion, a price-to-earnings ratio of 66.47, a PEG ratio of 4.16 and a beta of 1.40. Doximity has a 12 month low of $22.96 and a 12 month high of $61.75.

Institutional Investors Weigh In On Doximity

Large investors have recently modified their holdings of the business. MetLife Investment Management LLC lifted its position in shares of Doximity by 0.6% during the 3rd quarter. MetLife Investment Management LLC now owns 65,064 shares of the company's stock worth $2,835,000 after buying an additional 363 shares during the last quarter. First Horizon Advisors Inc. raised its stake in Doximity by 22.5% during the third quarter. First Horizon Advisors Inc. now owns 2,094 shares of the company's stock worth $91,000 after acquiring an additional 384 shares in the last quarter. GAMMA Investing LLC lifted its holdings in shares of Doximity by 40.1% in the third quarter. GAMMA Investing LLC now owns 1,439 shares of the company's stock worth $63,000 after acquiring an additional 412 shares during the last quarter. Van ECK Associates Corp boosted its stake in shares of Doximity by 19.7% in the 2nd quarter. Van ECK Associates Corp now owns 2,590 shares of the company's stock valued at $72,000 after purchasing an additional 427 shares in the last quarter. Finally, Cornercap Investment Counsel Inc. grew its holdings in shares of Doximity by 3.2% during the 2nd quarter. Cornercap Investment Counsel Inc. now owns 17,143 shares of the company's stock valued at $479,000 after purchasing an additional 537 shares during the last quarter. Institutional investors and hedge funds own 87.19% of the company's stock.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.